6 studies found for:    j1037
Show Display Options
Rank Status Study
1 Terminated Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery
Conditions: Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer
Interventions: Drug: azacitidine;   Drug: entinostat;   Other: laboratory biomarker analysis
2 Recruiting 20120231: Describe the Long-term Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: AMG 416
3 Terminated VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: A-002, varespladib methyl;   Drug: Placebo
4 Active, not recruiting 20120229: Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Interventions: Drug: AMG 416;   Drug: Placebo
5 Recruiting Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Exenatide Once Weekly;   Drug: Placebo
6 Recruiting 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Condition: Asthma
Interventions: Drug: ADVAIR 100/50mcg;   Drug: ADVAIR 250/50mcg;   Drug: FLOVENT 100mcg;   Drug: FLOVENT 250mcg

Indicates status has not been verified in more than two years